INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Akorn, Inc. of Pendency of Class Action Lawsuit and a Lead Plaintiff Deadline of May 4, 2015 -- AKRX


NEW YORK, April 20, 2015 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:

To: All persons or entities who purchased or otherwise acquired common shares of Akorn, Inc. (Nasdaq:AKRX) between April 17, 2014 and March 2, 2015.

You are hereby notified that a securities class action lawsuit has been commenced in the United States District Court for the Northern District of Illinois. If you purchased or otherwise acquired Akorn, Inc. ("Akorn") securities between April 17, 2014, and March 2, 2015, your rights may be affected by this action.

To get more information, click here: http://zlk.9nl.com/akorn-akrx.

The complaint alleges that: (a) as of December 31, 2014 Akorn has yet to integrate subsidiaries Hi-Tech Pharmacal Co., Inc. and VersaPharm Incorporated into its centralized accounting department and accounting systems; (b) certain data related to these subsidiaries could not be timely collected and compiled; and (c) Akorn's internal control over financial reporting was ineffective and material weaknesses existed relating to the completeness and accuracy of underlying data used in the determination of significant estimates and accounting transactions and accurate and timely reporting of its financial results and disclosures in its Form 10-K.

If you suffered a loss in Akorn you have until May 4, 2015 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff. To obtain additional information, contact Joseph E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or visit http://zlk.9nl.com/akorn-akrx.

Levi & Korsinsky is a national firm with offices in New York, New Jersey, Connecticut and Washington D.C. The firm's attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.



            

Contact Data